Abstract
This paper presents estimates of the impact of exemption status, and other socio-economic variables, on pharmaceutical use in Russia. Estimates are derived, from a newly collected household survey covering around four thousand households. Separate results for a zero-inflated negbin model of utilisation of prescriptions and for a two-part model of the overall level of household expenditure on pharmaceuticals are presented. Full exemption from prescription charges is shown to increase the utilisation of prescription items and reduce the probability of the households incurring drug expenditure. (C) 1999 Elsevier Science B.V. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 459-472 |
| Number of pages | 14 |
| Journal | Journal of health economics |
| Volume | 18 |
| Issue number | 4 |
| Publication status | Published - Aug 1999 |
Keywords
- Russia
- pharmaceuticals
- count data
- cost sharing
- copayments
- user charges
- DEMAND
- SELECTION
- HEALTH